Published Tuesday, June 9, 2015 4:00 pm
by Eva M. Stimson, EMS MC, Inc.

Sunnyvale, CA, June 9, 2015----The Parkinson’s Institute and Clinical Center located in Sunnyvale, CA, announces that Dr. Rohit Dhall has been invited to deliver a presentation on the evaluation of the extended-release formulation of carbidopa-levodopa (CD-LD, aka IPX066), in relation to individuals living with Parkinson’s disease at the 19th Annual International Congress of Parkinson’s Disease and Movement Disorders Conference to be held at the Manchester Grand Hyatt in San Diego, located at 1 Market Place, San Diego, CA, on June 14-18, 2015. Dr. Rohit Dhall recently joined the Parkinson’s Institute and Clinical Center from the Barrow Neurological Institute in Phoenix, Arizona, where he was Associate Professor of Neurology, Medical Director of Neuromodulation, and Director of the National Parkinson Foundation (NPF) Center of Excellence at the Muhammad Ali Parkinson Center.

Visit for a complete professional bio on Dr. Dhall.

Parkinson's Institute Physician,
Dr. Rohit Dhall,  to present at
San Diego Movement Disorder

Dr. Dhall remarks, “I’m honored to be invited to present at this conference regarding the findings we have discovered through clinical trials conducted on the evaluation of the efficacy of IPX066 in advanced Parkinson’s disease patients, specifically the group with troublesome dyskinesia before switching to IPX066. IPX066 was administered for 13 weeks in a double-blind, parallel group study vs. immediate release CD-LD (IR) in advanced PD patients. We found that advanced PD patients with troublesome dyskinesia randomized to IPX066 demonstrated a significantly greater improvement in motor disability measures without worsening of dyskinesia when compared to CD-LD IR.” Log onto the event website for additional information:

Dr. Dhall trained in medicine at the All India Institute of Medical Sciences (AIIMS) the premier medical training institution in India. He went on to complete a six-month post-doctoral training in psychiatry at AIIMS and then relocated to the United States where he completed his residency at the University of Alabama at Birmingham (UAB). Dr. Dhall also completed a fellowship in clinical movement disorders and Deep Brain Stimulation (DBS) while at UAB. Dr. Dhall has a Masters of Science in Epidemiology from the University of Texas at Houston School of Public Health and completed his internship in medicine at the University of Texas at Houston Department of Internal Medicine.

About the International Parkinson and Movement Disorder Society:

The International Parkinson and Movement Disorder Society (MDS), an international society of over 5,000 clinicians, scientists, and other healthcare professionals, is dedicated to improving patient care through education and research. For more information about MDS, visit

About the Parkinson’s Institute and Clinical Center

Two and a half decades ago, Dr. J. William Langston and a dedicated group of Parkinson’s disease experts set out to create a better way to research and provide care for Parkinson’s disease. Patients would become partners in developing their care plans, improving their quality of life, and discovering new strategies to confront and manage their disease. Compassionate care would work hand in hand with cutting-edge research to seek answers, develop new therapies and treatments, and ultimately work toward a cure. The result was the Parkinson’s Institute and Clinical Center—based in Sunnyvale, California—America’s only independent non-profit organization combining world-class care, clinical research, laboratory research, and clinical trials for Parkinson’s disease under one roof. The Institute focuses on areas including: biomarker discovery and clinical research; translational research on genetic forms of Parkinson’s; a world class LRRK2 research and drug discovery program (LRRK2 is the most common cause of familial or inherited Parkinson’s disease); stem cell modeling referred to as “Parkinson’s disease in a Petri dish”; and clinical trials and research on the non-motor or non-movement related and early features of Parkinson’s. Visit,, and or call direct to (408) 734-2800 or toll free, (800) 655-2273.

Send this page to a friend

Show Other Stories

2500 Hospital Drive, Bldg #10, Suite 1 | Mountain View, CA 94040
650.770.0201 main | 650.770.0204 fax (Clinic Secure)